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alumniprofile
increase in head size, and seizures.The juvenile form,
which has an onset between ages 2 and 13, is less common,
and adult onset forms are even more rare.
“Alexander disease had been presumed as a genetic
disorder but no one had any clue what gene was
responsible for it,” explains Dr. Messing, who is now
faculty core director, Rodent Models Core, and professor,
comparative biosciences, at the University of Wisconsin’s
Waisman Center.“Because we had essentially recreated one
of the hallmark features of the disease simply by changing
expression of the GFAP gene, we put that forward as a
candidate for the gene responsible for the disorder.”
During the ensuing four years, Dr. Messing’s lab
assembled the world’s largest collection of Alexander
disease samples, and found that greater than 90 percent of
patients with the disorder have mutations in the GFAP
gene. For a time, his lab was the world resource for
genetic testing for Alexander disease.With such striking
results, the testing quickly moved from the lab into
standard clinical practice.
“I’m very gratified that we discovered something that’s
really made a contribution to this disorder and a difference
in people’s lives,” Dr. Messing reflects.“Alexander disease
takes over the world of these patients and their families.

“

The exceptional flexibility of

the combined degree program
enabled me to focus on

neuropathology and develop

”

it as my clinical specialty.

Getting a clear diagnosis really matters to these parents.
Ultimately, we hope to develop a treatment, and we’ve
already started working toward that challenging goal.”
Going forward, Dr. Messing’s research may have
implications for a broader spectrum of neurologic and
neurodegenerative disorders, including epilepsy,Alzheimer’s
disease and Parkinson’s disease. “Astrocytes are increasingly
viewed by the scientific community as central players in a
variety of neurologic disorders,” he emphasizes.“We’d like
to learn how astrocyte dysfunction contributes to
Alzheimer’s and Parkinson’s, as well as Alexander disease,
and ultimately, how to modulate and possibly improve
astrocyte function and protect these cells from injury.”
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ames Thomson,V’88, developmental biologist
and anatomy professor at the University of
Wisconsin–Madison, was part of a team of
researchers who discovered how to turn human
skin cells into what appear to be embryonic stem
cells without having
to create or destroy
an embryo.The
finding is a critical
scientific accomplishment that
potentially will make
human embryos
unnecessary in
obtaining blank-slate
stem cells capable of
becoming any of the
220 cell types in the
human body.
In the new study—the results of which appear in
the December 21, 2007 issue of Science—Dr.
Thomson and his colleagues introduced a set of four
genes into human fibroblasts (skin cells easy to
obtain and grow in culture) to induce the skin cells
into a pluripotent state, a condition essentially the
same as that of embryonic stem cells. In addition to
eliminating ethical and political issues from the stem
cell debate, using reprogrammed skin cells allows for
customization to the patient.
“The induced cells do all the things embryonic
stem cells do,” explains Dr.Thomson. “It’s going to
completely change the field.”
Although Dr.Thomson is encouraged that the
new cells will speed up new cell-based therapies to
treat disease, more work is required, he says, to refine
the techniques through which the cells were generated to prevent incorporation of the introduced
genes into the genome of the cells. In addition, to
ensure their safety for therapy, methods to remove
the vectors—the viruses used to ferry the genes into
the skin cells—must be developed.
Dr.Thomson, who studied in the laboratory of
Dr. Ralph Brinster while at Penn Vet, also was the
first scientist to coax stem cells from human embryos
in 1998.
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